Simona Skerjanec
CIK: 0002022163
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 5, 2026IMUX
IMMUNIC, INC.
Award(A)DirectStock Option
25.4K shares- - Jun 29, 2026IMUX
IMMUNIC, INC.
Award(A)DirectStock Option
25.4K shares- - Feb 27, 2026RNA
Atrium Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
20K shares- - Feb 27, 2026RNAM
Avidity Biosciences, Inc.
Disposition(D)Direct6.7K shares- - Jun 10, 2025RNA
Avidity Biosciences, Inc.
Award(A)Direct6.7K shares- - Jun 5, 2025IMUX
IMMUNIC, INC.
Award(A)DirectStock Option
150K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 5, 2026 | IMUX IMMUNIC, INC. | Award(A) Stock Option | 25,370 | - | - | Direct |
| Jun 29, 2026 | IMUX IMMUNIC, INC. | Award(A) Stock Option | 25,370 | - | - | Direct |
| Feb 27, 2026 | RNA Atrium Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 20,000 | - | - | Direct |
| Feb 27, 2026 | RNAM Avidity Biosciences, Inc. | Disposition(D) | 6,692 | - | $0 | Direct |
| Jun 10, 2025 | RNA Avidity Biosciences, Inc. | Award(A) | 6,692 | - | - | Direct |
| Jun 5, 2025 | IMUX IMMUNIC, INC. | Award(A) Stock Option | 150,000 | - | - | Direct |
1-6 of 6 transactions
About Skerjanec Simona
Skerjanec Simona (SEC CIK 0002022163) files insider reports with the SEC as Director of IMMUNIC, INC. (IMUX), Director of Atrium Therapeutics, Inc. (RNA) and Director of Avidity Biosciences, Inc. (RNAM).
Signal8 holds 7 ownership filings by Skerjanec Simona (1 Form 3, 6 Form 4), filed between Jun 9, 2025 and Jul 7, 2026. Those filings report 6 transactions, from Jun 5, 2025 to Jul 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Skerjanec Simona's filings is in NEW YORK, NY.
Recent filings by Skerjanec Simona
- Jul 5, 2026: Grant or award of IMUX derivative securities (Form 4, code A).
- Jun 29, 2026: Grant or award of IMUX derivative securities (Form 4, code A).
- Feb 27, 2026: Grant or award of RNA derivative securities (Form 4, code A).
- Feb 27, 2026: Disposition to issuer transaction of RNAM shares (Form 4, code D).
- Jun 10, 2025: Grant or award of RNA shares (Form 4, code A).
Other insiders filing for IMMUNIC, INC. (IMUX)
- Nagel Robert Thorvald, Director
- BVF PARTNERS L P/IL, Director
- Ridloff Elena, Director
- Rudick Richard Alan, Director
- PHILLIPS BARCLAY A, Director
- Neermann Joerg, Director